NCT04460625View on ClinicalTrials.gov

Effect of Blood Group on the Survival Status of Intensive Care Patients

CompletedOBSERVATIONAL
Enrollment

3,114

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

February 5, 2022

Study Completion Date

February 7, 2022

Conditions
Critical IllnessNurse's RoleRisk FactorPrognosis
Trial Locations (1)

67100

Zonguldak Atatürk State Hospital, Zonguldak

All Listed Sponsors
lead

Zonguldak Bulent Ecevit University

OTHER

NCT04460625 - Effect of Blood Group on the Survival Status of Intensive Care Patients | Biotech Hunter | Biotech Hunter